Volume 9, Issue 3 (7-2011)                   IJRM 2011, 9(3): 239-242 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rabiee S, Farimani M, Ahmadi M. Evaluation of the effect of oral ritodrine on implantation rate in in-vitro fertilization-embryo transfer cycles. IJRM. 2011; 9 (3) :239-242
URL: http://ijrm.ssu.ac.ir/article-1-223-en.html
1- Department of Obstetrics and Gynecology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran , rabieesogol@yahoo.com
2- Department of Obstetrics and Gynecology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
Abstract:   (1914 Views)
Background: Pregnancy rate with IVF cycle is almost 22%. Many investigations perform to increase this rate in IVF. Various factors affect the result of IVF cycles. One of these factors could be uterine contractions that expel transferred embryo. Ritodrine is a beta mimetic agent that can block and decrease uterine contractions.
Objective: The objective of this study was to determine ritodrine effectiveness for increasing the implantation rate in IVF cycles, and its probable mechanisms in decreasing uterine contractions as well.
Materials and Methods: A total of 100 patients of IVF-ET cycles were divided randomly in two groups in a university hospital, Hamadan, Iran. The case group were prescribed ritodrine 10 mg / bid orally after oocyte retrieval until 10 days. The control group didn’t received ridotrine.
Results: In ritodrine group 14% of patients and in control group 16% had positive β-hCG test (p-value>0.5).
Conclusion: Ritodrine did not improve the implantation rate in IVF-ET cycles.
Full-Text [PDF 186 kb]   (266 Downloads) |   |   Full-Text (HTML)  (138 Views)  
Type of Study: Original Article |

1. Speroff L, Fritz M. Clinical Gynecologic Endocrinology and Infertility. Philadelphia, Lippincot Williamas & Wilkins 2005.
2. Gibbs RS, Karlan BY. Danforth's Obstetrics and Gynecology 2003. 9th Ed. Philadelphia; Williams & Wilkins; 2003: 590-592.
3. Leese B, Denton J. Attitudes towards single embryo transfer, twin and higher order pregnancies in patients undergoing infertility treatment: a review. Hum Fertil (Camb) 2010; 13: 28-34. [DOI:10.3109/14647270903586364]
4. Fanchin R, Righini C, de Ziegler D, Olivennes F, Ledée N, Frydman R. Effects of vaginal progesterone administration on uterine contractility at the time of embryo transfer. Fertil Steril 2001; 75: 1136-1140. [DOI:10.1016/S0015-0282(01)01787-3]
5. Gholami H, Vicari E, Molis M, La Vignera S, Papaleo E, Cappiello F. Pregnancy outcome following in vitro fertilization-embryo transfer (IVF-ET) in women aged < 37, undergoing ovulation induction with human FSH compared with recombinant FSH: a randomised controlled study. Eur Rev Med Pharmacol Sci 2010; 14: 97-102.
6. Nakai A, Togashi K, Kosaka K, Kido A, Kataoka M, Koyama T, et al. Do anticholinergic agents suppress uterine peristalsis and sporadic myometrial contractions at cine MR imaging? Radiology 2008; 246: 489-496. [DOI:10.1148/radiol.2461062091]
7. Pierzynski P, Reinheimer TM, Kuczynski W. Oxytocin antagonists may improve infertility treatment. Fertil Steril 2007; 88: 19-22. [DOI:10.1016/j.fertnstert.2006.09.017]
8. Kido A, Togashi K, Hatayama H, Nakayama T, Yamamoto A, Kataoka M, et al. Uterine peristalsis in women with repeated IVF failures: possible therapeutic effect of hyoscine bromide. J Obstet Gynaecol Can 2009; 31: 732-735. [DOI:10.1016/S1701-2163(16)34278-5]
9. Fanchin R, Righini C, Olivennes F, Taylor S, de Ziegler D, Frydman R. Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization. Hum Reprod 1998; 13: 1968-1974. [DOI:10.1093/humrep/13.7.1968]
10. Dal Prato L, Borini A. Effect of piroxicam administration before embryo transfer on IVF outcome: a randomized controlled trial. Reprod Biomed Online 2009; 19: 604-609. [DOI:10.1016/j.rbmo.2009.06.009]
11. Moon HS, Park SH, Lee JO, Kim KS, Joo BS. Treatment with piroxicam before embryo transfer increases the pregnancy rate after in vitro fertilization and embryo transfer. Fertil Steril 2004; 82: 816-820. [DOI:10.1016/j.fertnstert.2004.02.140]
12. Gorkemli H, Ak D, Akyurek C, Aktan M, Duman S. Comparison of pregnancy outcomes of progesterone or progesterone + estradiol for luteal phase support in ICSI-ET cycles. Gynecol Obstet Invest 2004; 58: 140-144. [DOI:10.1159/000079115]
13. Akande V, Garas A, Cahill D. The effect of diclofenac and paracetamol on pregnancy and implantation rates in infertile women undergoing IVF treatment. J Obstet Gynecol 2006; 26: 785-787. [DOI:10.1080/01443610600984578]
14. Pinheiro OL, Cavagna M, Baruffi RL, Mauri AL, Petersen C, Franco JG Jr. Administration of beta2-adrenergic agonists during the peri-implantation period does not improve implantation or pregnancy rates in intracytoplasmic sperm injection (ICSI) cycles. J Assist Reprod Genet 2003; 20: 513-516. [DOI:10.1023/B:JARG.0000013652.17193.38]
15. Hasegawa I, Yamanoto Y, Suzuki M, Murakawa H, Kurabayashi T, Takakuwa K, et al. Prednisolone plus low-dose aspirin improves the implantation rate in women with autoimmune conditions who are undergoing in-vitro fertilization. Fertil Steril 1998; 70: 1044-1048. [DOI:10.1016/S0015-0282(98)00343-4]
16. Bulletti C, de Ziegler D. Uterine contractility and embryo implantation. Curr Opin Obstet Gynecol 2006; 18: 473-484. [DOI:10.1097/01.gco.0000233947.97543.c4]

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb